Previous close | 0.0001 |
Open | 0.0002 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0001 - 0.0002 |
52-week range | 0.0001 - 0.0005 |
Volume | |
Avg. volume | 23,079,043 |
Market cap | 220,294 |
Beta (5Y monthly) | 90.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | 21 July 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Houston, Feb. 27, 2023 (GLOBE NEWSWIRE) -- . Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive, advanced content platform targeting dermatological and other health and wellness concerns, announced today that is joining Faire B2B Wholesale Marketplace to expend its domestic and internal market access and further grow its brands. Fai
Proprietary AI Platform, New Partnerships and New “Natural & Clinical Hybrid” products will drive the value creation in 2023; Further improvement in Cap Table to increase Shareholders valuationHouston, Texas, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content platform targeting derm
Increased Revenues and Reduced Debt (through retiring Notes) in 2022 Establish the Foundation for the Company’s Transformative Growth in 2023Houston, Texas, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, www.acnease.com a Botanical Therapeutics® Company and the provider of proprietary all botanical medicinal products (Botanical Therapeutics®) and interactive advanced content platform targeting dermatological and other health and wellness concerns, s